Eiko Lifesciences Ltd Nine Monthly Results

Gross Sales

26.39

9.73

3.23

Excise Duty

0

0

0

Net Sales

26.39

9.73

3.23

Other Operating Income

0

0

0

Other Income

0.49

0.1

0.03

Total Income

26.88

9.83

3.27

Total Expenditure

24.95

13.37

3.63

PBIDT

1.93

-3.54

-0.36

Interest

0.09

0.21

0.11

PBDT

1.84

-3.76

-0.47

Depreciation

0.49

0.14

0.13

Minority Interest Before NP

0

0

0

Tax

0.27

0.02

0.01

Deferred Tax

0.09

-1.04

-0.16

Reported Profit After Tax

1

-2.88

-0.44

Minority Interest After NP

0.01

-1.38

-0.16

Net Profit after Minority Interest

1.06

-1.5

-0.28

Extra-ordinary Items

0

0

0

Adjusted Profit After Extra-ordinary item

1.06

-1.5

-0.28

EPS (Unit Curr.)

0.82

-3.92

-0.72

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

12.87

3.82

3.82

Public Shareholding (Number)

0

0

0

Public Shareholding (%)

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

7.31

-36.38

-11.14

PBDTM(%)

6.97

-38.64

-14.55

PATM(%)

3.78

-29.59

-13.62